Pei Hu Selected Research

imigliptin

1/2021	Dipeptidyl-Peptidase-IV Inhibitors, Imigliptin and Alogliptin, Improve Beta-Cell Function in Type 2 Diabetes.
11/2018	A high-performance liquid chromatography-tandem mass spectrometry method for simultaneous determination of imigliptin, its five metabolites and alogliptin in human plasma and urine and its application to a multiple-dose pharmacokinetic study.
8/2018	Metabolites characterization of a novel DPP-4 inhibitor, imigliptin in humans and rats using ultra-high performance liquid chromatography coupled with synapt high-resolution mass spectrometry.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pei Hu Research Topics

Disease

21	Neoplasms (Cancer) 01/2021 - 07/2011
15	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 07/2011
8	Infections 01/2020 - 11/2014
7	Rheumatoid Arthritis 11/2021 - 01/2016
6	Systemic Lupus Erythematosus (Libman-Sacks Disease) 11/2021 - 11/2016
5	Type 2 Diabetes Mellitus (MODY) 01/2021 - 01/2009
4	Osteoporosis 06/2021 - 05/2013
4	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 01/2018
4	Diarrhea 01/2018 - 08/2014
3	Hypoxia (Hypoxemia) 07/2022 - 01/2019
3	Sepsis (Septicemia) 01/2022 - 01/2017
3	Nausea 05/2021 - 08/2014
3	Diabetes Mellitus 01/2021 - 01/2017
3	Liver Diseases (Liver Disease) 09/2019 - 11/2014
3	Ischemic Stroke 08/2018 - 12/2008
3	Hepatitis B 03/2018 - 09/2015
3	Exanthema (Rash) 01/2018 - 07/2009
3	Ovarian Epithelial Carcinoma 03/2014 - 01/2013
2	Body Weight (Weight, Body) 01/2022 - 07/2020
2	Hemorrhage 01/2022 - 07/2017
2	Disease Progression 01/2022 - 07/2011
2	Inflammation (Inflammations) 10/2021 - 07/2019
2	Constipation 01/2021 - 01/2020
2	Parkinson Disease (Parkinson's Disease) 05/2020 - 02/2019
2	Hypertension (High Blood Pressure) 01/2020 - 01/2010
2	Measles 01/2018 - 06/2015
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2018 - 05/2014
2	Headache (Headaches) 10/2016 - 07/2009
2	Chronic Obstructive Pulmonary Disease (COPD) 09/2016 - 06/2015
2	Dizziness (Lightheadedness) 02/2016 - 08/2014
2	Myalgia 02/2016 - 07/2009
2	Neoplasm Metastasis (Metastasis) 01/2014 - 03/2013
1	Chronic Renal Insufficiency 07/2022
1	Anemia 07/2022
1	Thrombosis (Thrombus) 01/2022
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 11/2021
1	Experimental Arthritis 08/2021
1	Vomiting 05/2021
1	Insulin Resistance 01/2021
1	Osteosarcoma (Osteogenic Sarcoma) 09/2020

Drug/Important Bio-Agent (IBA)

15	Pharmaceutical PreparationsIBA 07/2022 - 08/2011
10	Proteins (Proteins, Gene)FDA Link 04/2021 - 01/2016
8	Tyrosine Kinase InhibitorsIBA 01/2022 - 07/2009
7	icotinibIBA 09/2015 - 07/2011
6	abivertinibIBA 01/2022 - 11/2016
6	ErbB Receptors (EGF Receptor)IBA 12/2018 - 07/2011
3	kukoamine BIBA 01/2022 - 01/2017
3	imigliptinIBA 01/2021 - 08/2018
3	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2021 - 02/2017
3	GlypicansIBA 01/2019 - 01/2018
3	Liposomes (Liposome)IBA 01/2018 - 02/2013
3	VaccinesIBA 01/2018 - 06/2015
3	Vincristine (Oncovin)FDA LinkGeneric 01/2018 - 02/2013
3	PlatinumIBA 03/2014 - 01/2013
2	EnzymesIBA 07/2022 - 01/2021
2	Monoclonal AntibodiesIBA 11/2021 - 11/2016
2	LipopolysaccharidesIBA 10/2021 - 03/2017
2	Palonosetron (Aloxi)FDA Link 05/2021 - 01/2021
2	Small Interfering RNA (siRNA)IBA 09/2020 - 01/2019
2	CholesterolIBA 07/2020 - 02/2013
2	Polysaccharides (Glycans)IBA 07/2020 - 12/2018
2	Neuroprotective AgentsIBA 05/2020 - 12/2008
2	BilirubinIBA 01/2020 - 07/2009
2	Alanine Transaminase (SGPT)IBA 01/2020 - 01/2018
2	teriflunomideIBA 08/2019 - 07/2019
2	Leflunomide (Arava)FDA LinkGeneric 08/2019 - 07/2019
2	SodiumIBA 08/2019 - 07/2019
2	Biomarkers (Surrogate Marker)IBA 05/2019 - 09/2015
2	TabletsIBA 04/2019 - 11/2017
2	CurcuminIBA 01/2019 - 09/2017
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 08/2015
2	CateninsIBA 01/2019 - 01/2018
2	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 08/2018 - 01/2009
2	Transaminases (Aminotransferases)IBA 01/2018 - 01/2018
2	Antiviral Agents (Antivirals)IBA 09/2017 - 11/2014
2	Gefitinib (Iressa)FDA Link 03/2016 - 03/2013
2	Cytochrome P-450 CYP2C19IBA 01/2014 - 12/2012
1	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 07/2022
1	roxadustatIBA 07/2022
1	Factor XI (Plasma Thromboplastin Antecedent)IBA 01/2022
1	AntibodiesIBA 11/2021
1	Enhancer of Zeste Homolog 2 ProteinIBA 10/2021
1	AdiponectinIBA 06/2021
1	5-HT3 Serotonin Receptors (5 HT3 Receptor)IBA 05/2021
1	Adenosine Triphosphate (ATP)IBA 01/2021
1	alogliptinIBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	netupitantIBA 01/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021
1	Insulin-Like Growth Factor II (Somatomedin A)IBA 01/2021
1	polyethylene glycol-recombinant human growth hormoneIBA 01/2021
1	Insulin-Like Growth Factor Binding Protein 2IBA 01/2021
1	artenimol (dihydroartemisinin)IBA 11/2020
1	Cofilin 1IBA 09/2020

Therapy/Procedure

5	Oral Administration 08/2021 - 09/2016
5	Drug Therapy (Chemotherapy) 05/2021 - 07/2011
3	Therapeutics 01/2021 - 07/2009
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 08/2021 - 10/2016
2	Glycemic Control 07/2015 - 01/2009
1	Transplantation 09/2020